Incumaker announces completed acquisition for Cryogenic Therapy Company

By IVCPOST Staff Reporter

Sep 09, 2013 07:46 PM EDT

Today, Incumaker Inc. announced that it had completed its acquisition of CryoMist I and CryoMist II. It had also announced its third acquisition of CryoMist III that was said to close by early 2014.

CryoMist is the forefront of Cryogenic Therapy. The latter is the general use of low temperatures in medical therapy. CryoMist works to stimulate the body's natural healing abilities. This is done through using extreme cold to induce response in three levels.

Treatments that make use of CryoMist are administered individually for three minutes. The brain stimulates the regulatory functions of the body's organ results to increased energy due to extreme cold. The therapy also includes cell rejuvenation, immune system boost and overall self-healing. According to studies, each treatment increases metabolism and burns 500 to 800 calories in the next few hours. Anti-aging benefits could also be taken from using the therapy due to the production of collagen.

© 2024 VCPOST, All rights reserved. Do not reproduce without permission.

Join the Conversation

Real Time Analytics